Viatris (VTRS) Reports Q1 Earnings: What Key Metrics Have to Say

08.05.25 15:30 Uhr

Werte in diesem Artikel
Aktien

8,06 EUR -0,27 EUR -3,27%

Indizes

5.659,9 PKT -4,0 PKT -0,07%

Viatris (VTRS) reported $3.25 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 11.2%. EPS of $0.50 for the same period compares to $0.67 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $3.23 billion, representing a surprise of +0.81%. The company delivered an EPS surprise of +2.04%, with the consensus EPS estimate being $0.49.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Viatris performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Sales- Developed Markets: $1.89 billion versus the two-analyst average estimate of $1.93 billion. The reported number represents a year-over-year change of -12.6%. Net Sales- Greater China: $555.50 million versus the two-analyst average estimate of $553.02 million. The reported number represents a year-over-year change of +2.1%. Other revenues: $11.10 million versus the two-analyst average estimate of $9.95 million. The reported number represents a year-over-year change of +12.1%. Net Sales- Emerging Markets: $519.90 million versus the two-analyst average estimate of $463.79 million. The reported number represents a year-over-year change of -17%. Total Net Sales: $3.24 billion compared to the $3.26 billion average estimate based on two analysts. The reported number represents a change of -11.2% year over year. Net Sales- JANZ: $276.10 million versus $308.99 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -13.1% change. View all Key Company Metrics for Viatris here>>>Shares of Viatris have returned +10.4% over the past month versus the Zacks S&P 500 composite's +11.3% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Viatris Inc. (VTRS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Viatris und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Viatris

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Viatris

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Viatris Inc Registered Shs

Wer­bung